Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Research Reports > Electrophysiology Devices Market Size To Reach USD 12308.9 Million By 2026 – Reports and Data

Research Reports

Electrophysiology Devices Market Size To Reach USD 12308.9 Million By 2026 – Reports and Data

Published by news degree

Posted on August 4, 2021

Featured image for article about [object Object]

Increasing use in diagnosis of cardiovascular diseases, introduction of new technologies and advanced mapping technologies and growing geriatric population are key factors contributing to high CAGR of Electrophysiology Devices market during the forecast period.

According to the current analysis of Reports and Data, the global Electrophysiology Devices market was valued at USD 5055.3 Million in 2018 and is expected to reach USD 12308.9 million by the year 2026, at a CAGR of 11.6%. Electrophysiology (EP) is immensely popular due to its efficacy in terms of controlling and treating arrhythmia. Arrhythmia continues to be one of the significant cardiac disorders, preceded by sudden cardiac death (SCD), accounting for approximately 15-20% of total deaths. Electrophysiology devices are forcing their way through entrenched preferences for conventional methods to treat cardiac arrhythmia. According to WHO, cardiovascular diseases caused 17.5 million deaths globally in 2012. It became the leading cause of non -communicable disease (NCD) deaths. Electrophysiology devices are cardiology specialty devices used primarily in the diagnosis and treatment of cardiac arrhythmias. Thus, the growing prevalence of cardiovascular diseases is expected to boost Electrophysiology Devices market growth. The rising number of sudden cardiac arrest cases is a big threat to the American population. Rising use of defibrillators has proved helpful to reduce the death rates among patients suffering from cardiac arrest outside hospitals.

Introduction of new technologies such as Cryoablation, laser ablation, and ultrasound ablation and advanced mapping technologies are also likely to boost the demand for the Electrophysiology Devices market. Increasing accessibility to healthcare facilities, rising medical tourism, and the increasing incidences of heart failure cases are expected to augment market demand in emerging economies. But, high costs associated with Electrophysiology Devices, presence of strict regulations, and availability of alternative therapies are restraining market growth.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2277

Further key findings from the report suggest

The cryoablation segment is anticipated to grow at a CAGR of xx % during the forecast period
Electrophysiology (EP) technology has been advancing rapidly with new ablation tools to improve atrial fibrillation (AF) treatments, miniaturized diagnostic monitoring systems, and new implantable rhythm management devices that are making procedures much less invasive. Leadless Pacemakers, Wireless CRT, subcutaneous ICDs, new electro mapping systems, ultrasound guidance in Electrophysiology labs
The radiofrequency and cryoablation are the most widely used Electrophysiology ablation catheters
Asia-Pacific is a densely-populated region, with India and China being the most populated countries. Emerging economies, such as India and China, provide attractive growth opportunities for electrophysiological device manufacturers. The growth is augmented by the surge in demand for advanced electrophysiology devices, an improvement of healthcare reforms, high prevalence of cardiac arrhythmias, and increased focus of key players for developing technologically advanced cost-effective electrophysiology devices in this region. However, the unfavorable reimbursement scenario for electrophysiology devices, low awareness among physicians and patients about different electrophysiology devices, and high cost of these devices are likely to impede the electrophysiology devices market growth in these countries. In Japan, the atrial fibrillation rate among geriatric population is 2-3%. With the rise in ageing population, it is estimated that atrial fibrillation will affect about one million people by 2050, thereby driving the electrophysiology devices market growth.
Advances in the electrophysiology (EP) devices landscape has paced up in recent years. One such trend in the electrophysiology devices market is the introduction of leadless pacemakers. Leadless pacemakers serve as viable alternatives to the conventional variants, especially in case of patients who have a history of device infections. Traditional pacemakers are emerging as a major area of concern, as they are associated with a substantial risk of morbidity. This is laying a strong foundation for a faster adoption of leadless pacemakers.
The global Electrophysiology Devices market is highly fragmented with major players like Abbott Laboratories (U.S.), Bio sense Webster, Inc. (U.S.), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), GE Healthcare among others that collectively constitute a competitive market

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2277

Segments covered in the report

This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the Electrophysiology devices market on the basis of product, indication application and region:

Product (Revenue in Million USD; 2016–2026)

EP Ablation Catheters
- Cryoablation EP Catheters
- Radiofrequency Ablation Catheters
  - Irrigated-tip Radiofrequency Ablation Catheters
  - Conventional Radiofrequency Ablation Catheters
- Microwave Ablation Systems
- Laser Ablation Systems
- Navigational Advanced Mapping Accessories
EP Laboratory Devices
- EP X-Ray Systems
- 3D Mapping Systems
- EP Recording Systems
- EP Remote Steering Systems
- Others
EP Diagnostic Catheters
- Conventional EP Diagnostic Catheters
  - Steerable Diagnostic Catheters
  - Fixed Diagnostic Catheters
- Advanced EP Diagnostic Catheters
- Ultrasound EP Diagnostic Catheters

Access Devices
Others

Indication (Revenue in Million USD; 2016–2026)

Atrial Fibrillation (AF)
Atrial Flutter
Wolff-Parkinson-White Syndrome (WPW)
Atrioventricular Nodal Reentry Tachycardia (AVNRT)
Right Atrial Tachycardia
Right Atrial Flutter
Left Atrial Flutter
Right Ventricular Tachycardia
Left Ventricular Tachycardia

Regional Outlook (Revenue in Million USD; 2016–2026)

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Spain
- Benelux
- Italy
Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Australia
- Rest of Asia-Pacific
Middle East & Africa
- Saudi Arabia
- South Africa
- Egypt
- Israel
- Rest of MEA
Latin America
- Brazil
- Argentina
- Rest of Latin America

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2277

Key Points Covered in the Report:

Key insights into the latest growth trends, developments, technological and product advancements, and research and development scenario
Analysis of micro- and macro-economic factors and regulatory framework
In-depth evaluation of factors such as cost, capacity, rates of production and consumption, gross revenue, profit margin, demand and supply ratio, import/export, market share, market size, and market trends
SWOT analysis, Porter’s Five Forces Analysis, investment return analysis, and feasibility analysis to offer a comprehensive view of the competitive landscape
Strategic recommendations to established market players and new entrants to overcome limitations and entry-level barriers in the global market landscape
Analysis of market drivers, restraints, challenges, limitations, threats, growth prospects and opportunities

Thank you for reading the report. The report can be customize as per requirements of the clients. For further information or query about customization, please reach out to us and we will offer you the report best suited for your needs.

Explore Reports and Data’s Prime Analysis of the global Healthcare & Pharmaceutical Industry:

Pet Insurance Market @ https://www.google.com.co/url?q=https://reportsanddata.com/report-detail/pet-insurance-market

Veterinary Diagnostic Imaging Market @ https://www.google.co.ve/url?q=https://reportsanddata.com/report-detail/veterinary-diagnostic-imaging-market

Pharmaceutical Packaging Market @ https://www.google.lv/url?q=https://www.reportsanddata.com/report-detail/global-pharmaceutical-packaging-market

Healthcare Regulatory Affairs Outsourcing Market @ http://google.dz/url?q=https://www.reportsanddata.com/report-detail/healthcare-regulatory-affairs-outsourcing-market

Cannabidiol (CBD) Market @ https://www.google.com.sv/url?q=https://www.reportsanddata.com/report-detail/cannabidiol-cbd-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: [email protected]

Read Full Press Release: https://www.reportsanddata.com/press-release/global-electrophysiology-devices-market

The post Electrophysiology Devices Market Size To Reach USD 12308.9 Million By 2026 – Reports and Data first appeared on News Degree | Hub for Latest and Trending News from Around the Globe.